NewEdge Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.7K | Buy |
541
+4
| +0.7% | +$256 | ﹤0.01% | 2773 |
|
|
2025
Q1 | $34.1K | Sell |
537
-27
| -5% | -$1.71K | ﹤0.01% | 2678 |
|
|
2024
Q4 | $37.5K | Sell |
564
-52
| -8% | -$3.46K | ﹤0.01% | 2621 |
|
|
2024
Q3 | $43K | Sell |
616
-158
| -20% | -$11K | ﹤0.01% | 2486 |
|
|
2024
Q2 | $50.2K | Buy |
774
+238
| +44% | +$15.4K | ﹤0.01% | 2345 |
|
|
2024
Q1 | $34.7K | Buy |
536
+159
| +42% | +$10.3K | ﹤0.01% | 2429 |
|
|
2023
Q4 | $24.8K | Buy |
377
+20
| +6% | +$1.32K | ﹤0.01% | 2492 |
|
|
2023
Q3 | $20.4K | Buy |
357
+89
| +33% | +$5.08K | ﹤0.01% | 2378 |
|
|
2023
Q2 | $16.4K | Buy |
268
+175
| +188% | +$10.7K | ﹤0.01% | 2435 |
|
|
2023
Q1 | $5.84K | Sell |
93
-497
| -84% | -$31.2K | ﹤0.01% | 2728 |
|
|
2022
Q4 | $31.6K | Buy |
+590
| New | +$31.6K | ﹤0.01% | 1938 |
|